Teladoc Health, Inc. (TDOC) Revenue CAGR:-1.50%(TTM)
Revenue CAGR uses precomputed financial statement history.
Over longer horizons, Teladoc Health, Inc.'s Revenue CAGR averages 0.59% over 3 years and 12.97% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how Teladoc Health, Inc.'s top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
TDOC Revenue CAGR Chart
Teladoc Health, Inc. (TDOC)
TDOC Quarterly Revenue Growth (YoY)
Revenue growth vs the same quarter one year earlier, last 20 quarters.
TDOC Revenue CAGR History
| Year | Start Revenue | End Revenue | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $2.57B | $2.53B | $-39.60M | -1.54% | -1.54% |
| 2024 | $2.60B | $2.57B | $-32.84M | -1.26% | -1.26% |
| 2023 | $2.41B | $2.60B | +$195.57M | +8.13% | +8.13% |
| 2022 | $2.03B | $2.41B | +$374.13M | +18.41% | +18.41% |
| 2021 | $1.09B | $2.03B | +$938.75M | +85.81% | +85.81% |
| 2020 | $553.31M | $1.09B | +$540.65M | +97.71% | +97.71% |
| 2019 | $417.91M | $553.31M | +$135.40M | +32.40% | +32.40% |
| 2018 | $233.28M | $417.91M | +$184.63M | +79.14% | +79.14% |
| 2017 | $123.16M | $233.28M | +$110.12M | +89.42% | +89.42% |
| 2016 | $77.38M | $123.16M | +$45.77M | +59.15% | +59.15% |
| 2015 | $43.53M | $77.38M | +$33.86M | +77.78% | +77.78% |
| 2014 | $19.91M | $43.53M | +$23.62M | +118.67% | +118.67% |
Quarterly Revenue: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $613.85M | -4.4% | -2.5% |
| Q4 2025 | $642.27M | +2.5% | +0.3% |
| Q3 2025 | $626.44M | -0.9% | -2.2% |
| Q2 2025 | $631.90M | +0.4% | -1.6% |
| Q1 2025 | $629.37M | -1.7% | -2.6% |
| Q4 2024 | $640.49M | -0.0% | -3.0% |
| Q3 2024 | $640.51M | -0.3% | -3.0% |
| Q2 2024 | $642.44M | -0.6% | -1.5% |
| Q1 2024 | $646.13M | -2.2% | +2.7% |
| Q4 2023 | $660.53M | +0.0% | +3.6% |
| Q3 2023 | $660.24M | +1.2% | +8.0% |
| Q2 2023 | $652.41M | +3.7% | +10.1% |
| Q1 2023 | $629.24M | -1.3% | +11.3% |
| Q4 2022 | $637.71M | +4.3% | +15.1% |
| Q3 2022 | $611.40M | +3.2% | +17.2% |
| Q2 2022 | $592.38M | +4.8% | +17.7% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita